ANNUAL%20REPORT%202015%20eng
ANNUAL%20REPORT%202015%20eng
ANNUAL%20REPORT%202015%20eng
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Notes to Consolidated Financial Statements<br />
2 SIGNIFICANT ACCOUNTING POLICIES (Continued)<br />
(e)<br />
Associates and joint ventures (Continued)<br />
In all other cases when the Group ceases to have significant influence over an associate or joint control<br />
over a joint venture, it is accounted for as a disposal of the entire interest in that investee, with a<br />
resulting gain or loss being recognised in profit or loss. Any interest retained in that former investee at<br />
the date when significant influence or joint control is lost is recognised at fair value and this amount is<br />
regarded as the fair value on initial recognition of a financial asset (see Note 2(f)).<br />
(f)<br />
Other investments in debt and equity securities<br />
The Group’s and the Company’s policies for investments in debt and equity securities, other than<br />
investments in subsidiaries, associates and joint ventures, are as follows:<br />
Investments in debt and equity securities are initially stated at fair value, which is their transaction price<br />
unless it is determined that the fair value at initial recognition differs from the transaction price and<br />
that fair value is evidenced by a quoted price in an active market for an identical asset or liability or<br />
based on a valuation technique that uses only data from observable markets. Cost includes attributable<br />
transaction costs, except where indicated otherwise below. These investments are subsequently<br />
accounted for as follows, depending on their classification.<br />
Investments in securities which do not fall into categories of investments in securities held for<br />
trading neither dated debt securities are classified as available-for-sale securities. At the end of each<br />
reporting period the fair value is remeasured, with any resultant gain or loss being recognised in other<br />
comprehensive income and accumulated separately in equity in the fair value reserve. As an exception<br />
to this, investments in equity securities that do not have a quoted price in an active market for an<br />
identical instrument and whose fair value cannot otherwise be reliably measured are recognised in the<br />
statement of financial position as cost less impairment losses (see note 2(k)).<br />
When the investments are derecognised or impaired (see note 2(k)), the cumulative gain or loss<br />
recognised in equity is reclassified to profit or loss. Investments are recognised/derecognised on the<br />
date the Group commits to purchase/sell the investments or they expire.<br />
(g)<br />
Derivative financial instruments<br />
Derivative financial instruments are recognised initially at fair value. At the end of each reporting period<br />
the fair value is remeasured. The gain or loss on remeasurement to fair value is recognised immediately<br />
in profit or loss.<br />
122<br />
Annual Report 2015